Physician Quick Search
By Name:
By Specialty:
314-TOP-DOCS
When you need to get the name of one of the nation’s top doctors as close to home as St. Louis, just call 314-TOP-DOCS (314-867-3627) or toll free 1-866-867-3627. This is the physician referral and health information line from Barnes-Jewish Hospital.
Your Healthy Update

Like us on Facebook
Text Size: S M L
Search

Radiology / Nuclear Medicine

Barry Alan Siegel, MD

Current Position
Professor, Radiology
Chief, Division of Nuclear Medicine
Professor, Medicine


Specialty Areas
Nuclear Medicine
Radiology
Diagnostic Radiology

Patients Seen At
Mallinckrodt Institute of Radiology
510 South Kingshighway Boulevard, West Pavilion, 956
St. Louis, MO  63110
(314) 362-1952
Fax:   (314) 362-2806
View Driving Directions

Mailing Address
Washington University School of Medicine, Department of Radiology
660 South Euclid Avenue, Campus Box 8223
St. Louis, MO  63110

Academic Office
Mallinckrodt Institute of Radiology
510 South Kingshighway Boulevard, West Pavilion, 956
St. Louis, MO  63110
(314) 362-2809

Areas of Clinical Interest
Nuclear medicine, nuclear imaging, PET, positron emission tomography, radioiodine treatment, radionuclide imaging

Board Certification
Diagnostic Radiology -- Certified
Nuclear Medicine -- Certified
Nuclear Radiology -- Certified

Medical Education
A.B.: Washington University, St. Louis, Missouri, 1966
Medical School: Washington University School of Medicine, St. Louis, Missouri, 1969
Residency: Diagnostic Radiology, Mallinckrodt Institute of Radiology, Washington University, St. Louis, MO, 1973
Fellowship: Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University, St. Louis, MO, 1973
Hospital Affiliations
Barnes-Jewish Hospital
Barnes-Jewish West County Hospital
St. Louis Children's Hospital

Honors and Awards
Listed in Best Doctors in America, 1992-2014 (Best Doctors, Inc.)
Listed in America's Top Doctors, 2002-2014 (Castle Connolly Medical Ltd.)
Georg Charles de Hevesy Nuclear Pioneer Award for Outstanding Contributions to Nuclear Medicine, Society of Nuclear Medicine, 2003
Peter Valk Distinguished Clinical Scientist Award, Academy of Molecular Imaging. 2008
Distinguished Clinician Award, Washington University School of Medicine, 2013
Benedict Cassen Prize, Society of Nuclear Medicine and Molecular Imaging, 2014

Editorial Responsibilities

Editorial Board
Clinical and Translational Imaging
European Journal of Nuclear Medicine and Molecular Imaging

Editorial Consultant
Journal of Nuclear Medicine

Selected or Recent Journal Articles
Sasanelli M, Meignan M, Haioun C, Berriolo-Riedinger A, Casanovas RO, Biggi A, Gallamini A, Siegel BA, Cashen AF, Véra P, Tilly H, Versari A, Itti E. Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging 2014; 41:2017-2022.

Markovina S, Grigsby PW, Schwarz JK, DeWees T, Moley JF, Siegel BA, Perkins SM. Treatment approach, surveillance and outcome of well-differentiated thyroid cancer in childhood and adolescence. Thyroid 2014; 24:1121-1126.


Hillner BE, Siegel BA, Hanna L, Duan F, Shields AF, Coleman RE. Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry. J Nucl Med 2014; 55:574-581.

Hillner BE, Tosteson AN, Tosteson TD, Wang Q, Song Y, Hanna LG, Siegel BA. Intended versus inferred care after PET performed for initial staging in the National Oncologic PET Registry. J Nucl Med 2013; 54:2024-2031.

Dehdashti F, Grigsby PW, Siegel BA. Response to the letter to the editor regarding the manuscript entitled "Positron emission tomography with [18F]-3'-deoxy-3'-fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study". Mol Imaging Biol 2013; 15:786-787.

Patel K, Hadar N, Lee J, Siegel BA, Hillner BE, Lau J. The lack of evidence for PET or PET/CT surveillance of patients with treated lymphoma, colorectal cancer, and head and neck cancer: a systematic review. J Nucl Med 2013; 54:1518-1527.

Itti E, Meignan M, Berriolo-Riedinger A, Biggi A, Cashen AF, Véra P, Tilly H, Siegel BA, Gallamini A, Casanovas RO, Haioun C. An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax. Eur J Nucl Med Mol Imaging 2013; 40:1312-1320.

Fowler K, McConathy J, Khanna G, Dehdashti F, Benzinger TLS, Miller-Thomas M, Parsons M, Raptis C, Grigsby P, Laforest R, Gropler RJ, Narra V, Siegel BA, Kotyk J, Priatna A, McKinstry R, Woodard PK. Simultaneous PET/MRI acquisition: clinical potential in anatomically focused and whole-body examinations. Appl Radiol 2013 June; 42(6):9-14.

Haseebuddin M, Dehdashti F, Siegel BA, Liu J, Roth EB, Nepple KG, Siegel CL, Fischer KC, Kibel AS, Andriole GL, Miller TR. 11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction. J Nucl Med 2013; 54:699-706.

Chang AJ, Dehdashti F, Siegel BA, Welch MJ, Schwarz JK, Grigsby PW. Intratumoral heterogeneity of 64Cu-ATSM uptake is a prognostic indicator in patients with cervical cancer. OMICS J Radiol 2013; 2:e130.

Hillner BE, Tosteson TD, Tosteson ANA, Wang Q, Song Y, Onega T, Hanna LG, Siegel BA. Intended versus inferred management after PET for cancer restaging: analysis of Medicare claims linked to a coverage with evidence development registry. Med Care 2013; 51:361-367.

Adkins D, Ley J, Trinkaus K, Thorstad W, Lewis J Jr, Wildes T, Siegel BA, Dehdashti F, Gay H, Mehan P, Nussenbaum B. A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck: a phase II prospective trial. Cancer 2013; 119:766-773.

Olsen JR, Esthappan J, DeWees T, Narra VR, Dehdashti F, Siegel BA, Schwarz JK, Grigsby PW. Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix. J Magn Reson Imaging 2013; 37:431-434.

Dehdashti F, Grigsby PW, Myerson RJ, Nalbantoglu I, Ma C, Siegel BA. Positron emission tomography with [18F]-3'-deoxy-3'-fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study. Mol Imaging Biol 2013; 15:106-113.

Machtay M, Duan F, Siegel BA, Snyder BS, Gorelick JJ, Reddin JS, Munden R, Johnson DW, Wilf LH, DeNittis A, Sherwin N, Cho KH, Kim S, Videtic G, Neumann DR, Komaki R, Macapinlac H, Bradley JD, Alavi A. Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial. J Clin Oncol 2013; 31:3823-3830.

For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. Barry Siegel

Washington University Physicians are the medical staff of  Barnes-Jewish Hospital and Children's Hospital - St. Louis Employment   About Us   Top Stories   For Your Protection      Site Map
Copyright 2014 Washington University School of Medicine
Copyright 2014 Washington University School of Medicine